Cost Comparison of Fibroid TreatmentWhen we consider the cost of a treatment we must look at the cost to the NHS in the short and longer term, the cost to the patients and their families, who may have to take time off work to look the woman and the costs to employers and society. It is important to people that they recover quickly and get back to normal life as soon as possible. Most women cannot afford to take 3 months off work, especially if they run their own business, have a senior position, are on piece work or have family responsibilities. NICE has not considered the costs to patients, their families and society in the past. The NHS has a tariff which is an average cost of treatment in England. The table below shows the current tariff and there are considerable savings to be made for the NHS. Each year the NHS introduces new NHS Tariffs, which are the average cost of a procedure across the NHS in England. The Tariff costs below are for financial year 17/18 The Department of Health wants to encourage less hysterectomies and more less invasive treatments such as UFE.
In the table below we show how much the NHS could save if all the 60% of hysterectomies performed for fiobroids in England each year were converted to UFE. FEmISA does not advocate this as all women should have a choice in treatment, but most do not as they are not told of alternatives to hysterectomy.
Here is an analysis for England as a whole, on the savings that could be made if women had fully informed choice of their treatment options from a multi-disciplinary fibroid outpatients’ clinic run by interventional radiologists and gynaecologist working together for the benefit of women with fibroids. There are few of these clinics in the country, but one is at Heartlands Hospital in Birmingham. Here 60% of women with fibroids opt for UFE. This is a benchmark for the rest of the UK.
Potential Saving on In-Patient Costs from Treatments with Embolisation instead of Hysterectomy
Further potential cost savings
It is also important to look at some of the costs to patients and their families and employers. Reduction in cost of patients and their families
Reduction in Cost to the Economy, Employers and Society
Estimated Full Annual Costs of Fibroids in USA
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

Cost Comparisons